Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec 20;2(1):1-19.
doi: 10.3390/healthcare2010001.

Malignant Melanoma

Affiliations
Review

Malignant Melanoma

Eshini Perera et al. Healthcare (Basel). .

Abstract

Melanomas are a major cause of premature death from cancer. The gradual decrease in rates of morbidity and mortality has occurred as a result of public health campaigns and improved rates of early diagnosis. Survival of melanoma has increased to over 90%. Management of melanoma involves a number of components: excision, tumor staging, re-excision with negative margins, adjuvant therapies (chemo, radiation or surgery), treatment of stage IV disease, follow-up examination for metastasis, lifestyle modification and counseling. Sentinel lymph node status is an important prognostic factor for survival in patients with a melanoma >1 mm. However, sentinel lymph node biopsies have received partial support due to the limited data regarding the survival advantage of complete lymph node dissection when a micrometastasis is detected in the lymph nodes. Functional mutations in the mitogen-activated pathways are commonly detected in melanomas and these influence the growth control. Therapies that target these pathways are rapidly emerging, and are being shown to increase survival rates in patients. Access to these newer agents can be gained by participation in clinical trials after referral to a multidisciplinary team for staging and re-excision of the scar.

Keywords: cancer; malignant melanoma; melanin; melanocyte; melanoma; moles; nevus; nodular melanoma; skin cancer.

PubMed Disclaimer

References

    1. Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Zanetti R., Masini C., Boyle P., Melchi C.F. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur. J. Cancer. 2005;41:2040–2059. doi: 10.1016/j.ejca.2005.03.034. - DOI - PubMed
    1. Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Picconi O., Boyle P., Melchi C.F. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer. 2005;41:45–60. doi: 10.1016/j.ejca.2004.10.016. - DOI - PubMed
    1. Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Abeni D., Boyle P., Melchi C.F. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur. J. Cancer. 2005;41:28–44. doi: 10.1016/j.ejca.2004.10.015. - DOI - PubMed
    1. Bataille V. Early detection of melanoma improves survival. Practitioner. 2009;253:29–32. - PubMed
    1. Australian Institute of Health and Welfare . Cancer in Australia: An Overview 2012. AIHW; Canberra, Australia: 2012.

LinkOut - more resources